HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

TI-23 human monoclonal antibody

a passive immunotherapeutic agent for cytomegalovirus (CMV) infection; developed by Teijin Ltd.
Also Known As:
MCA C23-HSA-glycine; TI-23; lyophilized regavirumab-human serum albumin-amino acetic acid
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results